The 411 on a GLP-1

Could This GLP-1 RA be Right for Your Adult Patients With T2D?

Join leaders in the field of diabetes Dr. Jim Gavin, Dr. Pablo Mora, and Dr. Bob Busch as they navigate through a clinical study. What do you need to know about using a GLP-1 RA for glycemic control with patients who have T2D? Are there any considerations for specific populations such as those who have moderate renal impairment?


This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.


James gavin

 James R. Gavin III, MD, PhD, is a clinical professor of medicine at Emory University, and chief medical officer of Healing Our Village, Inc. in Atlanta, Georgia.







Robert Busch

 Robert Busch, MD, is the director of clinical research at Albany Med Faculty Practice and Community Endocrine Group, in Albany, New York.








Pablo Mora

 Pablo F. Mora, MD, FACE, MSc, CDCES, is an endocrinologist at North Texas Diabetes & Endocrinology and a clinical professor in the division of endocrinology at the University of Texas Southwestern Medical Center in Dallas, Texas. 

Submit Feedback